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THE REGIONAL CAPILLARY 
DISTRIBUTION OF 
RETROGRADE BLOOD 
CARDIOPLEGIA IN 
EXPLANTED HUMAN 
HEARTS 
Warm retrograde blood cardioplegia is frequently used for myocardial protection, 
despite experimental studies questioning the adequacy of capillary flow to the right 
ventricle and septum. The capillary distribution of retrograde blood cardioplegia in 
the human heart is unknown. Hearts from eight transplant recipients with the 
diagnosis of idiopathic or dilated cardiomyopathy were arrested in situ with cold 
blood cardioplegia nd excised with the coronary sinus intact. Within 20 minutes of 
explantation, colored microspheres mixed in 37 ° C blood cardioplegia were admin- 
istered through the coronary sinus at a pressure of 30 to 40 mm Hg for 2 minutes. 
Twelve transmural myocardial samples were taken horizontally at the level of 
midventricle and apex to determine regional capillary flow rates. When retrograde 
warm blood cardioplegia was administered at a rate of 0.42 -+ 0.06 ml/gm/min, the 
left ventricle, the septum, the posterior wall of the right ventricle, and the apex 
consistently received capillary flow rates in excess of their metabolic requirements. 
The capillary perfusion of anterior and lateral walls of the right ventricle was 
marginally adequate to sustain aerobic metabolism. In explanted human hearts, 
retrograde blood cardioplegia provides adequate capillary flow to the left ventricle, 
the septum, the posterior wall of the right ventricle, and the apex; however, capillary 
flow to the anterior and lateral walls of the right ventricle is marginal. This study 
delineates the tenuous balance between supply and demand for right ventricular 
protection with warm continuous retrograde blood cardioplegia. (J TrIORAC CAR- 
DIOVASC SURG 1995;109:935-40) 
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T he success of any cardioplegic formulation de- pends in large measure on the completeness of its 
delivery in terms of both distribution and flow rate. 
The antegrade delivery of cardioplegia into the 
aortic root ensures adequate distribution to both 
ventricles by means of unobstructed coronary arter- 
ies. Limitations of antegrade delivery include non- 
homogeneous distribution of the solution distal to 
coronary artery occlusions and the requirement for 
coronary osteal cannulation i procedures requiring 
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ascending aortotomy. 1 Retrograde administration f 
cardioplegia through the coronary sinus is increas- 
ingly being used as an alternative delivery method. 
This type of administration can be performed safely 
and continuously in nearly all types of cardiac 
surgical procedures except those involving venous 
system anomalies. 
In the presence of coronary artery occlusion, 
retrograde cardioplegia has been experimentally 
shown to be superior to antegrade cardioplegia in 
the delivery of capillary flow to jeopardized myocar- 
dium.2, 3 Several studies of retrograde coronary si- 
nus perfusion have demonstrated poor delivery of 
cardioplegic solution to the right ventricle and sep- 
turn, however, and the adequacy of protection is 
therefore questionable? -6 
Despite these experimental findings, multiple 
clinical studies attest to the efficacy of retrograde 
cardioplegia, even in the context of right ventricular 
hypertrophy. 7-9 The discrepancy between experi- 
mental and clinical studies may be related to the 
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Fig. 1. Horizontal cross-seetions of the explanted human heart where myocardial samples (shaded areas) 
were taken for microsphere analyses. 
invalidity of inferences from canine hearts to human 
hearts. 1° To our knowledge, there has been no 
published report of quantitative distribution of ret- 
rograde cardioplegia in human hearts. We therefore 
undertook this study to determine and quantify the 
capillary (nutritive) distribution of warm retrograde 
blood cardioplegia in explanted human hearts with 
idiopathic or dilated cardiomyopathy. 
Methods 
Cardioplegic solution. Blood cardioplegia was pre- 
pared by mixing ABO-compatible blood with crystalloid 
cardioplegia solution in a 4:1 ratio. The crystalloid cardio- 
plegia solution was composed of 500 ml 5% dextrose in 
watet, 0.2 normal saline solution, 200 ml 0.3 mol/L tris 
(hydroxymethyl) aminomethane (Abbott Laboratories, 
Abbott Park, Ill.), 50 ml citrate-phosphate-dextrose solu- 
tion (Abbott), and 60 mEq potassium chloride. Heparin 
(2000 U/dl), caMum chloride (50 mg/dl), and sodium 
bicarbonate (approximately 8 mEq/dl) were then added 
and the cardioplegia solution was oxygenated by bubbling 
with 100% oxygen for approximately 5 minutes. The 
composition and eharacteristics of the final cardioplegia 
solution were as foUows: hematocrit, 20%, oxygen tension, 
150 mm Hg, carbon dioxide tension, less than 60 mm Hg; 
pH 7.4; sodium, 170 mEq; potassium, 40 mEq, calcium, 
0.5 mEq; ehloride, 95 mEq, glucose, 800 mg/dl; and 
osmolality, 450 mOsm/L. The blood cardioplegia solution 
was prepared within 1 hour of administration. 
Explantation of human hearts. The explanted hearts 
from eight recipients undergoing heart transplantation 
with the diagnosis of end-stage idiopathie or dilated 
cardiomyopathy were the subjects of this study. These 
hearts were obtained from transplant recipients who (1) 
laeked any angiographic or pathologic evidence of coro- 
nary artery disease, (2) had no previous cardiac opera- 
tions, and (3) had histologic evidence, either before or 
during operation, of idiopathic ardiomyopathy with in- 
terstitial fibrosis. This research protocol was in accordance 
with the institutional guidelines for the use of pathologic 
specimens. 
At the time of orthotopic heart transplantation, 4°C 
blood cardioplegia was administered into the aortic root 
for 2 minutes at 80 mm Hg to cause in situ arrest. The 
hearts then underwent an extended subatrial explantation 
to ensure intaet removal of coronary sinus and venous 
drainage systems of both ventricles. The hearts were 
placed in iced saline solution and immediately transferred 
to the laboratory for further study. 
Experimental protocol. The explanted hearts were 
weighed, and both right and left coronary ostea were 
cannulated with heparin and safine-filled intravenous 
tubing. A silk tie was tied around the coronary arteries 
and tubing. A purse-string suture of 1-0 Prolene (Ethicon, 
Inc., Somerville, N.J.) was placed around the coronary 
sinus and a 16F straight aortic perfusion cannula (DLP, 
Inc., Grand Rapids, Mich.) was introduced into the coro- 
nary sinus. The purse-string suture was tied around the 
coronary sinus cannula. Both coronary osteal lines and the 
coronary sinus cannula were flushed. The free atrial edges 
were occluded with vascular clamps. 
The heart was then suspended by a heavy suture placed 
through the aorta and pulmonary artery. Warm blood 
cardioplegia (37 ° C) was delivered at a pressure of 30 to 
40 mm Hg for 2 minutes. A solution containing approxi- 
mately 2,500,000 colored microspheres (15 _+ 5/xm) was 
then injected into the coronary sinus infusion line during 
the first 30 seconds of cardioplegia dministration. The 
effluents from right coronary artery, left coronary artery, 
and thebesian venous system (collected in ventricular 
cavities) were collected. 
Sample collection. The hearts were transected horizon- 
tally at the level of midventricle and apex (Fig. 1). Two 
horizontal slices were removed at the midventricular nd 
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Table I. Regional capillary flow rate of retrograde blood cardioplegia in various areas of explanted human 
hearts 
Anterior Lateral Posterior Middle L V R V IVS 
RV 17.6 ± 4.4 18.3 ± 6.3 29.4 -4- 15.1 
LV 46.6 + 15.4 49.3 + 18.3 76.1 + 25.7 
Septum 31.1 ± 10.1 22.5 ± 5.4 24.3 ± 14.0 
Apex 74.4 ± 21.9 27.1 ± 5.9 47.8 ± 10.2 
Data are mean -+ standard error of the mean, expressed in milliliters per 100 gm per minute. LV, Left ventricle; RV, right ventricle;/VS, interventricular 
septum. 
apical levels. A 2.5 gm myocardial sample was excised 
from the following areas at the midventricular level: the 
anterior, posterior, and lateral walls of the right ventricle; 
the anterior, posterior, and lateral walls of the left ventri- 
cle; and the anterior, middle, and posterior sections of the 
interventricular septum. Similar myocardial samples were 
obtained from the lateral eft ventricular free wall, the 
middle interventricular septum, and the lateral right ven- 
tricular free wall at the level of the apex. 
Mierosphere analysis. All samples were processed ac- 
cording to the recommendations of E-Z Trac Inc. (Los 
Angeles, Calif.). The manufacturer's names for the vari- 
ous reagents are used. 11 Each myocardial sample was 
weighed and stored with 15 ml of Tissue Digest Reagent 
1. The processing included placing the sample in boiling 
watet bath for 1 hour, vortex mixing for 1 minute, diluting 
to 40 ml with Tissue Digest Reagent II, and centrifuging 
for 30 minutes. Supernatant was poured oft and the 
sample was resuspended in 4 ml of Tissue Microsphere 
Counting Reagent. The sample was washed three times 
with 2 ml of Tissue Microsphere Counting Reagent. The 
sample was again centrifuged and the supernatant was 
removed. Aliquots of the final solution were placed in an 
Improved Neubauer Hemocytometer (Hausser Scientific, 
Horsham, Pa.). Twelve chambers were counted for each 
sample and the total number of microspheres in each 
myoeardial sample was calculated according to the follow- 
ing formula: 
No. counted 
Total microspheres = 
No. chambers ×0.9 mm 3 
1000 mm 3 
- ×ml suspension 
ml 
where No. counted isthe number of colored microspheres 
counted by the hemocytometer, No. chambers i the 
number of chambers counted, 0.9 mm 3 is the ruled volume 
of each chamber, and ml suspension is the final dilution 
volume. The concentration of microspheres in effluent 
samples were determined by employing a similar proto- 
CO1.11 
Flow ealeulations. The blood cardioplegia flow to each 
region was calculated from the following equation: 
qt × nu 
qu ~ - -  
nt 
where qt is the total cardioplegia flow rate delivered by the 
calibrated roller pump (in milliliters per minute), nù is the 
number of microspheres in the specimen of interest, and 
n« is the total number of microspheres counted in the 
heart as a whole (2,500,000 - number of microspheres 
recovered in efttuents). 
Statistical analyses. The capillary flow rates to the 
anterior and lateral walls of right ventricle were compared 
with the left ventricular posterior wall capillary flow rate 
by means of repeated-measures analysis of variance and 
paired t test. 
Resu l ts  
Capillary (nutritive) flow was based on the num- 
ber of rnicrospheres recovered from each region of 
myocardium. The regional capillary distribution of 
warm blood cardioplegia dministered through the 
coronary sinus is shown in Table I. The left ventric- 
ular free walls, interventricular septum, posterior 
wall of the right ventricle, and apex were consis- 
tently perfused. The retrograde coronary sinus nu- 
tritive flow was consistently lower in the right ven- 
tricular anterior and lateral wall (anterior wall, 17.6 
_ 4.4 ml .gm -1"min- I ;  lateral wall, 18.3 _-_ 6.3 
ml" gm -1" min-a). The capillary flow rates to the 
anterior and lateral walls of the right ventricle were 
significantly lower than the flow rate to the posterior 
wall of the left ventricle (p --- 0.05). The mean 
retrograde blood cardioplegia flow rate in explanted 
human hearts was 155 +_ 24 ml/min; with the range 
of 89 to 272 tal/min (Table II). The mean flow rate 
per gram of myocardium was 0.42 ___ 0.06 ml/min. 
Duplicate myocardial specimens of varying 
weights were taken from three explanted hearts and 
analyzed for microsphere concentrations. Results 
were similar, attesting to the absence of the "twin- 
kling" phenomenon, variability in microsphere con- 
centration caused by size of the examined specimen. 
Additionally, when two different batches of colored 
microspheres were injected simultaneously, the mi- 
crosphere concentrations were again similar (data 
not shown). This finding confirms the adequacy of 
mixing during delivery. To investigate the possibility 
of microsphere adherence to cardioplegia tubing 
and cannula, after two experiments we analyzed 
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Table II. Retrograde blood cardioplegic ftow rates 
in explanted human hearts 
Cardioplegic flow rate 
Weight Total Adjusted 
Hearts (gin) (tal/min) (ml " min- 1. gm- i) 
i 428 125 0.29 
2 407 244 0.60 
3 376 105 0.28 
4 415 89 0.21 
5 437 158 0.36 
6 312 140 0.45 
7 354 272 0.77 
8 296 110 0.37 
Mean ± SEM 155 ± 24 0.42 ± 0.06 
SEM, Standard error of the rnean. 
multiple tubing samples and the coronary sinus 
cannula for microspheres. The proportion of adher- 
ent microspheres throughout the entire tubing was 
estimated at less than 6% and was therefore subse- 
quently disregarded. 
Discuss ion  
This study provides quantitative information on 
the capillary flow of warm retrograde blood cardio- 
plegia in explanted human hearts. Retrograde cor- 
onary sinus perfusion in explanted human hearts 
with normothermic blood cardioplegia provides ub- 
stantial capillary flow to the left ventricle, the sep- 
turn, and the posterior wall of the right ventricle at 
midventricular level, as well as at the apex. The 
regions that remain consistently hypoperfused 
(compared with the posterior wall of the left ventri- 
cle) are the anterior and lateral free walls of the 
right ventricle. 
The objective of cardioplegic preservation is to 
afford the heart the maximal protection against 
ischemic damage. This aim is realized by minimizing 
myocardial oxygen consumption while maximizing 
capillary delivery of cardioplegia to ensure aerobic 
homeostasis. Diastolic cardiac arrest with either 
normothermia or hypothermia substantially reduces 
myocardial oxygen consumption. 12 Cardioplegic 
techniques strive to meet this reduced oxygen eeds 
of the arrested heart. To put the regional myocardial 
flow rates obtained in this study into perspective, 
one needs to know the flow requirement of the 
arrested human heart under normothermic condi- 
tions. It has been conservatively estimated that at 
37 ° C, approximately 17 ml. 100 gm -1.min -1 of 
capillary cardioplegic flow is needed to meet the 
metabolic requirements of the arrested human 
heartJ 3 This estimate is based on the assumption of 
a hemoglobin level of 8 gm/dl, an oxygen saturation 
of 100%, a 60% oxygen extraction, and homoge- 
• 14 i neous myocardial cardiopleglc dehvery. Desp te its 
limitations, this theoretic estimate can be used as a 
crude reference point. It thus appears that retro- 
gradely administered warm blood cardioplegia pro- 
vides substantial capillary flow to all examined re- 
gions of explanted human heart except he anterior 
and lateral walls of the right ventricle, where the 
capillary flow is marginally adequate to support 
aerobic metabolism. 
An important part in the experimental protocol of 
this study was the placement of a purse-string suture 
around the coronary sinus. This maneuver appears 
to maximize the retrograde coronary sinus flow to 
the right ventricleJ 5 The results of this study may 
therefore be an overestimation of right ventricular 
capillary flow. Because the clinical situation does 
not usually include the use of a purse-string suture, 
suboptimal right ventricular capillary perfusion may 
occur with warm continuous retrograde blood car- 
dioplegia. 
This study delineates the tenuous balance of 
supply and demand for right ventricular protection 
with warm continuous retrograde blood cardiople- 
gia. The margin for error is quite small, and with this 
technique the right ventricle may have transient 
episodes of oxygen debt and anaerobic glycolysis. 
The findings of this study are in concordance with 
those of the experimental studies that question 
adequacy of the right ventricular protection with 
retrograde blood cardioplegia. 4's'16 The cardiac 
surgeon who uses this technique as the sole method 
of myocardial protection should be keenly aware of 
right ventricular vulnerability to warm anaerobic 
arrest. 
An important issue facing the cardiac surgeon 
employing warm retrograde cardioplegia is the flow 
rate. If retrograde warm cardioplegia sadministered 
at a rate of approximately 0.5 rel. gm 1. min-1 (ap- 
proximately 150 ml/min for a 300 gm heart), the 
capillary flow to different regions of the heart is 
probably similar to the distribution shown in this study, 
with flow to the right ventricular anterior and lateral 
walls marginally adequate to maintain aerobic metab- 
olism. 
The strength of this study is its use of the ex- 
planted human heart model and an experimental 
protocol designed to mimic the clinical situation• 
Explanted human hearts with angiographically and 
pathologicaUy proven absence of coronary artery dis- 
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ease were arrested under controlled circumstances; 
this provided a unique and valuable resource for 
investigation of cardioplegia distribution. The hearts 
were arrested with cold antegrade cardioplegia nd 
were prepared to receive the retrograde cardioplegia 
dose within 20 minutes of explantation. The experi- 
mental protocol was designed to recreate the clinical 
scenario. Conversely, a potential imitation of this 
study is the appropriateness of extrapolation of data 
derived from human hearts with idiopathic or dilated 
cardiomyopathy (with interstitial fibrosis and some 
ventricular hypertrophy) to human hearts with con- 
genital heart diseases, coronary artery diseases, or 
valvular heart diseases. The significance of this inher- 
ent shortcoming of the model remains unknown. 
This study provides quantitative data on the cap- 
illary distribution of warm retrograde blood cardio- 
plegia in explanted human hearts with idiopathic or 
dilated cardiomyopathy. The capillary flow rate to 
the left ventricle, the septum, and the posterior wall 
of the right ventricle at midventricular level and at 
the apex is sufficient o sustain aerobic homeostasis. 
There is limited warm blood cardioplegic flow to 
anterior and lateral walls of the right ventricle, barely 
enough to support warm aerobic metabolism. This 
study documents the tenuous protection of the right 
ventricle by warm retrograde blood cardioplegia. 
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Discussion 
Dr. Milton A. Meier (Rio de Janeiro, Brazil). For many 
years now, Drs. Jazbik and Kubrusly and I have done 
experiments with retrograde coronary perfusion in sheep 
and dogs. I would like to share some of out findings. 
In a group of six sheep, the Beck II operation was 
performed. A segment of autologous vein was interposed 
between the descending aorta and the coronary sinus, 
which was then ligated proximally. Both right and left 
coronary arteries were then ligated at the coronary ostia. 
The animals survived for between 5 and 16 days. All 
hearts were removed and contrast medium was injected 
into the vein that had been anastomosed to the coronary 
sinus. During the injections acinecoronariographyc study 
of the specimen was performed. In each heart, the first 
veins to show opacification were those originating from 
the right ventricle. Only in the subsequent s age of the 
injection did the left ventricle also show opacification. 
When the same study was performed with a catheter 
introduced into the coronary sinus, results varied. The 
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right ventricle was still the first cavity to show opacifica- 
tion in most animals; in some hearts, however the distri- 
bution of contrast medium was irregular. There was less 
contrast medium in the right ventricle than in the left. In 
those hearts, coronary veins draining proximally into the 
coronary sinus were found. 
On the basis of our experimental work and also of our 
good clinical results with retrograde cardioplegia through 
the coronary sinus and by way of the right atrium, we 
conclude the following: First, the right ventricle is well 
perfused by retrograde injection. Second, the coronary 
sinus cannula must be placed as rar proximally as possible. 
Dr. Ardehali. The findings of this study suggest that the 
right ventricle is protected; however, this protection is 
marginal. In the clinical setting, marginal protection may 
not be compatible with the aim of the cardiac surgeon. We 
therefore believe that retrograde warm blood cardioplegia 
may not be advisable as the sole method of protection. 
Furthermore, we believe that the purse-string suture 
placed as part of this experimental procedure caused 
overestimation f the degree of right ventricular capillary 
perfusion. Caution must therefore be exercised when 
retrograde warm cardioplegia is used as the only method 
of myocardial protection. 
Dr. Robert A. Guyton (Atlanta, GA.). I have a comment 
and a question. First, I would like to comment hat for 
some time we have used an external stitch around the 
coronary sinus. When you put the coronary sinus catheter 
in, it is extremely easy to lift up the catheter and, from the 
inferior surface of the heart, put a 3-0 Prolene stitch 
around the coronary sinus, use a snare on the suture, and 
then pull the coronary sinus catheter back. I think that it 
is possible to position the coronary sinus catheter near the 
origin of the coronary sinus without he catheter slipping 
out by means of this external suture. 
Second, we have used light microspheres and found, as 
you did, large variations from sample to sample. Were 
there statistical differences by analysis of variance between 
your samples? 
Dr. Ardehali. Thank you, Dr. Guyton. The placement of 
a purse-string suture in the clinical setting is a technique 
that would maximize the delivery of the retrograde car- 
dioplegia to the right ventricle, and it may actually be 
recommended if technically feasible. In terms of variabil- 
ity, as you noted there was some variabil~ty in the number 
of microspheres in each myocardial specimen. Analysis of 
variance was not performed between groups. When we 
compared the right ventricular lateral and anterior wall 
flow rates with the left ventricular posterior wall flow rate, 
however, a statistically significant difference was detected. 
Dr. Gordon N. Olinger (Milwaukee, Wis.). I am dis- 
turbed by the data from this study because for the last 21/2 
or 3 years now, I have been using continuous warm 
retrograde blood cardioplegia exclusively for coronary 
operations. I have had universally excellent results and 
have had absolutely no problems with right ventricular 
protection and postoperative performance. 
1 think that the issue here is the rate of delivery of 
cardioplegia. I note that in the breakdown of the total 
flows you deliver to these explanted hearts, only two of the 
hearts received rates of flow greater than 200 ml/min. In 
out clinical setting, we routinely have flows greater than 
200 tal/min, in large hearts orten as rauch as 300 ml/min, 
and we allow the coronary sinus pressure to rise to 50 or 
sometimes even 60 mm Hg. 
I think that this is really the single best explanation for 
the difference in clinical performance and results from 
some elegant laboratory studies, this one included, sug- 
gesting that the right ventricle may not be well protected. 
Dr. Ardehali. I think that you bring up an important 
point, one that I tried to emphasize. The data from this 
study should be viewed within the context of flow. The 
retrograde cardioplegic solution flow rate was 0.42 ml/gm/ 
min; for a 300 gm heart, the amount would be about 150 
ml per minute. If the flow rate goes beyond that, better 
perfusion or improvement in the capillary flow rate would 
be expected, which may be an explanation for clinical 
success with warm retrograde blood cardioplegia. In ad- 
dition, I think that one reason for the "clinical success" of 
warm retrograde cardioplegia is that the end points that 
have been used may not be sensitive indicators of right 
ventricular protection after operation. There also may be 
transient episodes of anaerobic arrest in the right ventri- 
cle. 
Dr. Joseph E. Flack (Springfield, Mass.). 1 would just 
like to say that we have been using continuous warm for 
about the last 4 years, about 2800 cases, and we have not 
seen any right ventricular problems. I think that the study 
is interesting, and there certainly is decreased right ven- 
tricular perfusion with retrograde techniques, but this 
does not seem to be a clinically significant finding. 
Dr. Ardehali. As I stated before, I think that the clinical 
significance of all our findings hould be viewed within the 
context of the flow rate. If the flow rate is increased, 
perfusion of the right ventricle would obviously improve. 
Additionally, the end points that we have used conven- 
tionally have not been sulIiciently sensitive indicators of 
right ventricular protection. If we used more sensitive 
indicators, we might be able to detect some subtle changes 
in right ventricular function. Right ventricular protection 
may be optimized by combining techniques, uch as the 
combination of antegrade and retrograde delivery. 
